Our Euroject® scientific poster has been approved, and we’re excited to share that Unither Pharmaceuticals will present at the World Vaccine Congress from March 30 to April 2 in Washington, US.

The poster highlights our partnership with ONCOVITA, reflecting a shared commitment to advancing solutions that could make a meaningful impact for patients.

This collaborative work provides a closer look at innovative approaches in vaccine delivery, hinting at new possibilities for safer, simpler, and more accessible immunisation.

Attendees are invited to explore the poster and see firsthand the exciting potential of this partnership.

We look forward to connecting with you and discussing future opportunities to collaborate and drive innovation in vaccine delivery.